Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

PharmaCyte Biotech, Inc.

CIK 0001157075PMCB· quarter ending 2026-06-30

Shares outstanding

10,735,649

as of 2026-09-11 · 10-Q cover page, filed 2026-09-14

Held by 13F filers

selection includes debt or preferreds — no % of shares outstanding

Holders

+0 vs 2026-03-31 · 1 new, 1 exited

Value

shares +42.9% vs prior quarter

Share classes (cover page of the 10-Q filed 2026-09-14, as of 2026-09-11)

Class	Listed	Shares outstanding	Held by 13F filers	% of class	Holders	CUSIP
Common stock	PMCB · NASDAQ	10,735,649	762,759	7.1%	28	71715X203

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine

Count	CUSIP	Class (as filers write it)	Holders	Shares held	Class shares	% of class	Value	Options	Mapped via
	71715X203	COM NEW	28	762,759	10,735,649	7.1%	$586K	1 call / 0 put	13DG	holders →
	71715X104	COMMON STOCKnot common	4	10	—	—	$7	—	prefix	holders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings.

Top holders (4 of 4 · 71715X104)

change vs 2026-03-31

#	Filer	Shares / principal	% of class	Value	Change
1	CoreCap Advisors, LLC	4	—	$3	NEW
2	HARBOUR INVESTMENTS, INC.	3	—	$2	—
3	CALDWELL SUTTER CAPITAL, INC.	2	—	$2	—
4	HUNTINGTON NATIONAL BANK	1	—	$0	—

Exited since 2026-03-31 (1 filers; largest 1 shown)

Fortitude Family Office, LLC

−1

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting person	Form	Filed	Event	Shares	% of class
Daniel B. Asher	SCHEDULE 13G/A	2026-02-13	2025-12-31	531,086	4.99%
Intracoastal Capital LLC	SCHEDULE 13G/A	2026-02-13	2025-12-31	532,254	4.99%
Mitchell P. Kopin	SCHEDULE 13G/A	2026-02-13	2025-12-31	532,254	4.99%
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B	SCHEDULE 13G/A	2025-02-13	2024-12-31	774,100	9.9%
Ayrton Capital LLC	SCHEDULE 13G/A	2025-02-13	2024-12-31	774,100	9.9%
Waqas Khatri	SCHEDULE 13G/A	2025-02-13	2024-12-31	774,100	9.9%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.